Lowering serum uric acid to prevent acute kidney injury

Medical Hypotheses

Volumn 78, Issue 6, 2012, Pages 796-799

  Ahsan Ejaz, A ^a   Dass, Bhagwan ^a   Kambhampati, Ganesh ^a   Ejaz, Noel I ^b   Maroz, Natallia ^a   Dhatt, Gurjit S ^a   Arif, Amir A ^a   Faldu, Chirag ^a   Lanaspa, Miguel A ^c   Shah, Gaurav ^a   Johnson, Richard J ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b The University of Chicago   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; URIC ACID;

ACUTE KIDNEY FAILURE; ARTICLE; CONTRAST INDUCED NEPHROPATHY; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HEART SURGERY; HUMAN; HYPERURICEMIA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; URIC ACID BLOOD LEVEL; VASOCONSTRICTION;

ACUTE KIDNEY INJURY; ANGIOGENESIS INHIBITORS; ANIMALS; CISPLATIN; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; KIDNEY; MODELS, BIOLOGICAL; PILOT PROJECTS; RATS; URATE OXIDASE; URIC ACID; VASOCONSTRICTION;

EID: 84860354658     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.03.011     Document Type: Article

References (45)

1. Kjellstrand C.M., Cambell D.C., von Hartitzsch B., Buselmeier T.J. Hyperuricemic acute renal failure. Arch Intern Med 1974, 133:349-359.
2. Spencer H.W., Yarger W.E., Robinson R.R. Alterations of renal function during dietary-induced hyperuricemia in the rat. Kidney Int 1976, 9:489-500.
3. Kim Y.G., Huang X.R., Suga S., Mazzali M., Tang D., Metz C., et al. Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy. Mol Med 2000, 6:837-848.
4. Conger J.D., Falk S.A. Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest 1977, 59:786-793.
5. Sánchez-Lozada L.G., Tapia E., Santamaría J., Avila-Casado C., Soto V., Nepomuceno T., et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005, 67:237-247.
6. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006, 17:1503-1520.
7. Ejaz A.A., Mu W., Kang D.H., Roncal C., Sautin Y.Y., Henderson G., et al. Could uric acid have a role in acute renal failure?. Clin J Am Soc Nephrol 2007, 2:16-21.
8. Hencz P., Deverall P.B., Crew A.D., Steel A.E., Mearns A.J. Hyperuricemia of infants and children: a complication of open heart surgery. J Pediatr 1979, 94:774-776.
9. Chesney R.W., Kaplan B.S., Freedom R.M., Haller J.A., Drummond K.N. Acute renal failure: an important complication of cardiac surgery in infants. J Pediatric 1975, 87:381-388.
10. Hamilton R.M., Crocker J.F., Murphy D.A. Uric acid metabolism of children who undergo cardiopulmonary bypass. Can J Surg 1982, 25:131-132.
11. Ejaz A.A., Beaver T.M., Shimada M., Sood P., Lingegowda V., Schold J.D., et al. Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients?. Am J Nephrol 2009, 30:425-429.
12. Lapsia V., Johnson R.J., Dass B., Shimada M., Kambhampati G., Ejaz N.I., et al. Elevated uric acid increases the risk for acute kidney injury. Am J Med 2012, 125:302. (e9-302 e17).
13. Ejaz A.A., Kambhampati G., Ejaz N.I., Dass B., Lapsia V., Arif A.A., et al. Comparison of serum uric acid and biomarkers to predict acute kidney injury. 49th European Renal Association-European Dialysis and Transplantation Association Congress Paris 2012, Abstract SAP 120.
14. Sánchez-Lozada L.G., Tapia E., López-Molina R., Nepomuceno T., Soto V., Avila-Casado C., et al. Effects of acute and chronic l-arginine treatment in experimental hyperuricemia. Am J Physiol Ren Physiol 2007, 292:F1238-F1244.
15. Mazzali M., Kanellis J., Han L., Feng L., Xia Y.Y., Chen Q., et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Ren Physiol 2002, 282:F991-F997.
16. Sánchez-Lozada L.G., Tapia E., Soto V., Avila-Casado C., Franco M., Zhao L., et al. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia. Nephrol Dial Transplant 2008, 23:1179-1185.
17. Kang D.H., Park S.K., Lee I.K., Johnson R.J. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005, 16:3553-3562.
18. Kanellis J., Watanabe S., Li J.H., Kang D.H., Li P., Nakagawa T., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293.
19. Sautin Y.Y., Nakagawa T., Zharikov S., Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007, 293:C584-C596.
20. Yu M.A., Sánchez-Lozada L.G., Johnson R.J., Kang D.H. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010, 28:1234-1242.
21. Gersch C., Palii S.P., Imaram W., Kim K.M., Karumanchi S.A., Angerhofer A., et al. Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids 2009, 28:118-149.
22. Perlstein T.S., Gumieniak O., Hopkins P.N., Murphey L.J., Brown N.J., Williams G.H., et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int 2004, 66:1465-1470.
23. Lu C.Y., Winterberg P.D., Chen J., Hartono J.R. Acute kidney injury: a conspiracy of toll-like receptor 4 on endothelia, leukocytes, and tubules. Pediatr Nephrol 2011, (Epub ahead of print).
24. Kinsey G.R., Sharma R., Huang L., Li L., Vergis A.L., Ye H., et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009, 20:1744-1753.
25. Marques V.P., Gonçalves G.M., Feitoza C.Q., Cenedeze M.A., Fernandes Bertocchi A.P., Damião M.J., et al. Influence of TH1/TH2 switched immune response on renal ischemia-reperfusion injury. Nephron Exp Nephrol 2006, 104:e48-e56.
26. Conforti-Andreoni C., Spreafico R., Qian H.L., Riteau N., Ryffel B., Ricciardi-Castagnoli P., et al. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. J Immunol 2011, 187:5842-5850.
27. Webb R., Jeffries M., Sawalha A.H. Uric acid directly promotes human T-cell activation. Am J Med Sci 2009, 337:23-27.
28. Kosugi T., Nakayama T., Heinig M., Zhang L., Yuzawa Y., Sanchez-Lozada L.G., et al. Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Ren Physiol 2009, 297:F481-F488.
29. Brooks C., Wei Q., Cho S.G., Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009, 119:1275-1285.
30. Funk J.A., Schnellmann R.G. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Ren Physiol 2011, (Epub ahead of print).
31. Romero F., Pérez M., Chávez M., Parra G., Durante P. Effect of uric acid on gentamicin-induced nephrotoxicity in rats-role of matrix metalloproteinases 2 and 9. Basic Clin Pharmacol Toxicol 2009, 105:416-424.
32. Morales A.I., Detaille D., Prieto M., Puente A., Briones E., Arévalo M., et al. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int 2010, 77:861-869.
33. Hong Q., Qi K., Feng Z., Huang Z., Cui S., Wang L., et al. Hyperuricemia induces endothelial dysfunction via mitochondrial Na(+)/Ca(2+) exchanger-mediated mitochondrial calcium overload. Cell Calcium 2012, (Epub ahead of print).
34. Doughan A.K., Harrison D.G., Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 2008, 102:488-496.
35. Roncal C.A., Mu W., Croker B., Reungjui S., Ouyang X., Tabah-Fisch I., et al. Effect of elevated serum uric acid on cisplatininduced acute renal failure. Am J Physiol Ren Physiol 2007, 292:F116-F122.
36. Ejaz AA, Dass B, Lingegowda V, Shimada M, Johnson RJ. The rasburicase pilot study for the prevention of acute kidney injury in CV surgery. Abstract ASN 2010, Denver.
37. Bennett M., Dent C.L., Ma Q., Dastrala S., Grenier F., Workman R., et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008, 3:665-673.
38. Ejaz AA, Asmar A, Shimada M, Kambhampati G, Ejaz NI, Arif AA, Alsabbagh M, Johnson RJ. Preoperative serum uric acid affects serum NGAL concentrations. ASN Abstract 2011, Philadelphia.
39. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
40. Obermayr R.P., Temml C., Gutjahr G., Knechtelsdorfer M., Oberbauer R., Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008, 19:2407-2413.
41. Johnson R.J., Lanaspa M.A., Gaucher E.A. Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations. Semin Nephrol 2011, 31:394-399.
42. Shimada M., Dass B., Ejaz A.A. Paradigm shift in the role of uric acid in acute kidney injury. Semin Nephrol 2011, 31:453-458.
43. Shimada M., Johnson R.J., May W.S., Lingegowda V., Sood P., Nakagawa T., et al. A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant 2009, 24:2960-2964.
44. Kaneko K., Taniguchi N., Tanabe Y., Nakano T., Hasui M., Nozu K. Oxidative imbalance in idiopathic renal hypouricemia. Pediatr Nephrol 2009, 24:869-871.
45. Sautin Y.Y., Johnson R.J. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 2008, 27:608-619.